Evidence map›Paper›PMID 22030503›Full record

ArticlePlastic and reconstructive surgery2011

Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase.

Jennifer E Bond, George Kokosis, Licheng Ren, M Angelica Selim, Andrew Bergeron, Howard Levinson

Open access · greenAbstract readComparative Study
In one paragraph

Article in Plastic and reconstructive surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Role of Myofibroblasts in Physiological and Pathological Tissue Repair.Cold Spring Harbor perspectives in biology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Deep Learning in Virtual Screening: Recent Applications and Developments.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Mechanotransduction in Wound Healing and Fibrosis.Journal of clinical medicine · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jennifer E BondDurham, N.C. From the Division of Plastic and Reconstructive Surgery, Department of Surgery, and the Department of Pathology, Duke University Medical Center.
George Kokosis
Licheng Ren
M Angelica Selim
Andrew Bergeron
Howard Levinson
Health First · USDuke University · USHoward University · US

Funding

Non Muscle Myosin II Contractility Putatively Regulates Scar ContractureK08GM085562 · NIGMS · DUKE UNIVERSITY · PI LEVINSON, HOWARD · 2008 to 2012
$713k
NIGMS NIH HHS K08 GM085562NIGMS NIH HHS K08 GM085562-01
6 · The paper itself

Abstract

backgroundDermal scarring and scar contracture result in restriction of movement. There are no effective drugs to prevent scarring. RhoA and Rho-associated kinase have emerged as regulators of fibrosis and contracture. Fasudil, a Rho-associated kinase inhibitor, has been demonstrated to have antifibrotic effects in models of liver, renal, and cardiac fibrosis. The role of fasudil in preventing dermal scarring and contractures has not been studied. The authors used a rat model of dermal wound healing to assess the effects of fasudil with regard to the prevention of scarring.

methodsHuman scar tissue and surrounding normal skin were immunostained for RhoA and Rho-associated kinase. Full-thickness wounds were created on Wistar-Han rats, and fasudil (30 mg/kg/day) or saline was continuously delivered subcutaneously. Wound contraction was measured by gravitational planimetry. After 21 days, tissue was harvested for Masson's trichrome, hematoxylin and eosin, Ki-67, and CD31 staining. Fibroblast-populated collagen lattices were used to assess the mechanistic effects of fasudil on contractility. Myofibroblast formation was assessed in the presence of fasudil.

resultsHuman scar tissue in the remodeling phase of repair showed increased expression of RhoA and Rho-associated kinase in scar tissue compared with surrounding normal tissue. Fasudil inhibited wound contraction as compared with controls. Hematoxylin and eosin and Masson's trichrome were similar between groups. Fasudil did not alter angiogenesis or proliferation. Fasudil inhibited fibroblast contractility and myofibroblast formation in vitro.

conclusionsThere is growing evidence that the RhoA/Rho-associated kinase pathway plays an important role in wound healing and scar contracture. The authors present data showing that inhibition of Rho-associated kinase hinders fibroblast contractility and may be beneficial in preventing scar contracture.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAdultAnimalsBiopsy, NeedleBlotting, WesternCicatrixDisease Models, AnimalFibroblastsHumansImmunohistochemistryInjections, SubcutaneousMiddle AgedProtein Kinase InhibitorsRandom AllocationRatsRats, Wistar1-(5-Isoquinolinesulfonyl)-2-MethylpiperazinefasudilProtein Kinase Inhibitorsrho-Associated Kinases

Identifiers

PMID22030503
PMCPMC3205419
OpenAlexW165538219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.